Stemmatters is a fully integrated CDMO whose core expertise addresses multiple investigational medicinal products (IMPs), including advanced therapy medicinal products (ATMPs), biologicals, and diverse raw materials supporting the product life cycle of innovative therapeutic products. Based in Barco, Portugal, the company has nearly two decades of experience with advanced cell therapies and other complex biologicals, developing both proprietary assets and those of their external partners. Stemmatters provides technology transfer procedures, product, process, and analytical development services tailored to each client’s needs.